Aytu BioScience is trading at $2.14, up 6.47%, with no specific catalyst identified.
- The company’s press-release page shows no release dated October 16, and no credible report explaining the rise surfaced in the search.
- The move runs counter to the supplied context: the biotech sector and major indexes are lower, so those trends do not clearly explain the gain.
- No reliable live volume or activity data was available to characterize trading.